User login
Key clinical point: Significant racial and ethnic disparities are reported in the use of prostate magnetic resonance imaging (MRI) following elevated prostate-specific antigen (PSA) test results.
Major finding: Black patients with PSA levels above 4 ng/mL and 10 ng/mL were 24.1% and 35.0% less likely to undergo subsequent prostate MRI, respectively, compared with White patients. Asian patients with PSA levels higher than 4 ng/mL were 24.1% less likely, and Hispanic patients with PSA levels above 10 ng/mL were 23.4% less likely to undergo subsequent prostate MRI than White patients.
Study details: A cohort study of 794,809 patients aged 40 years and above who received a single PSA result and no prior PSA screening or prostate MRI.
Disclosures: This work was supported by research funding from Harvey L. Neiman Health Policy Institute. Dr. Rosenkrantz reported employment with American Journal of Roentgenology. No other disclosures were reported.
Source: Abashidze N et al. JAMA Network Open. 2021 Nov 8. doi: 10.1001/jamanetworkopen.2021.32388.
Key clinical point: Significant racial and ethnic disparities are reported in the use of prostate magnetic resonance imaging (MRI) following elevated prostate-specific antigen (PSA) test results.
Major finding: Black patients with PSA levels above 4 ng/mL and 10 ng/mL were 24.1% and 35.0% less likely to undergo subsequent prostate MRI, respectively, compared with White patients. Asian patients with PSA levels higher than 4 ng/mL were 24.1% less likely, and Hispanic patients with PSA levels above 10 ng/mL were 23.4% less likely to undergo subsequent prostate MRI than White patients.
Study details: A cohort study of 794,809 patients aged 40 years and above who received a single PSA result and no prior PSA screening or prostate MRI.
Disclosures: This work was supported by research funding from Harvey L. Neiman Health Policy Institute. Dr. Rosenkrantz reported employment with American Journal of Roentgenology. No other disclosures were reported.
Source: Abashidze N et al. JAMA Network Open. 2021 Nov 8. doi: 10.1001/jamanetworkopen.2021.32388.
Key clinical point: Significant racial and ethnic disparities are reported in the use of prostate magnetic resonance imaging (MRI) following elevated prostate-specific antigen (PSA) test results.
Major finding: Black patients with PSA levels above 4 ng/mL and 10 ng/mL were 24.1% and 35.0% less likely to undergo subsequent prostate MRI, respectively, compared with White patients. Asian patients with PSA levels higher than 4 ng/mL were 24.1% less likely, and Hispanic patients with PSA levels above 10 ng/mL were 23.4% less likely to undergo subsequent prostate MRI than White patients.
Study details: A cohort study of 794,809 patients aged 40 years and above who received a single PSA result and no prior PSA screening or prostate MRI.
Disclosures: This work was supported by research funding from Harvey L. Neiman Health Policy Institute. Dr. Rosenkrantz reported employment with American Journal of Roentgenology. No other disclosures were reported.
Source: Abashidze N et al. JAMA Network Open. 2021 Nov 8. doi: 10.1001/jamanetworkopen.2021.32388.